• Study of trastuzumab with chemotherapy and immunotherapy combination for first-line treatment in patients with HER2-positive esophageal squamous cell cancer

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Denmark
  • Study of Plitidepsin Treatment for Adults with Post-COVID-19 Condition

    Not recruiting

    2 1 1
    Investigated diseases:
    Spain
  • Study of belantamab mafodotin combined with pomalidomide, dexamethasone, and daratumumab in patients with relapsed/refractory multiple myeloma who previously had 1-3 treatments and are lenalidomide resistant

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Greece
  • Study of HPV vaccine to prevent recurrence of External Genital Warts in previously cured patients: Comparing Human Papillomavirus vaccine versus placebo

    Not recruiting

    3 1 1
    Investigated diseases:
    France
  • Study of gemtuzumab ozogamicin and chemotherapy combinations in children with newly diagnosed acute myeloid leukemia, high-risk myelodysplastic syndrome, or myeloid sarcoma

    Not recruiting

    3 1 1 1
    Investigated diseases:
    France Ireland
  • Study on Risankizumab for Patients with Moderate to Severe Crohn’s Disease

    Not recruiting

    3 1
    Investigated diseases:
    Investigated drugs:
    Czechia Hungary Lithuania Poland
  • Study of Isatuximab with drug combination for newly diagnosed multiple myeloma patients with severe kidney problems

    Not recruiting

    2 1 1 1
    Greece
  • Study of RMC-6236 compared to standard therapy in previously treated metastatic pancreatic ductal adenocarcinoma

    Not recruiting

    3 1 1 1
    Investigated diseases:
    France Germany Italy Spain
  • Study on the Safety and Effects of Belantamab Mafodotin with Lenalidomide and Dexamethasone for Patients with Newly Diagnosed Multiple Myeloma Not Eligible for Transplant

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Greece
  • Study on the Safety and Effectiveness of PF-07104091 Alone or with Fulvestrant, Letrozole, and Palbociclib for Patients with Advanced Breast, Ovarian, or Lung Cancer

    Not recruiting

    1 1 1 1
    Bulgaria

powered by